Company: Volitionrx Ltd

VNRX

Stock Code:

Enter Stock Code:

This report provides insider trading pattern and statistics for "Volitionrx Ltd (VNRX)" . Please read important descriptions at the bottom of this report.

Register Free Insider Trade Email Alert for "Volitionrx Ltd (VNRX)" !



 

Analysis & Screening

Chart Screening Tool

  Transaction Date

  Filing Date

Start Date:

Select Start Date

End Date:

Select End Date

Trading History Screening Tool

Transaction Code:

Ownership:

Share Class:

Trade Price From:

to

Transaction History From March 22nd, 2017 To April 22nd, 2017 (Max 50 Records Displayed)

Filing Date

Trade Date

 

Insider Name

Event Code

Ownership

Trade Information

Holding % Change

Apr 19/17

Apr 18/17

Company Director Buy

Innes Guy Archibald

X

Direct ownership

Acquired 74,821 Common Stock at $2.60

6.08%

Apr 19/17

Apr 18/17

Company Director Sell

Innes Guy Archibald

X

Direct ownership

Disposed -74,821 Warrant (Right to Buy)

-100.00%

Apr 19/17

Apr 18/17

Company Director Sell

Innes Guy Archibald

X

Indirect ownership

Disposed -1,786 Warrant (Right to Buy)

-100.00%

Apr 19/17

Apr 18/17

Company Director Buy

Innes Guy Archibald

X

Indirect ownership

Acquired 1,786 Common Stock at $2.60

3.73%

Apr 11/17

Apr 10/17

CxO Buy

Vanston David Cecil

Chief Financial Officer

A

Direct ownership

Acquired 100,000 Stock Option (Right to Buy)

0.00%

Apr 05/17

Apr 03/17

Company Director Sell

Faulkes Martin Charles

X

Direct ownership

Disposed -58,034 Warrant (Right to Buy)

-100.00%

Apr 05/17

Apr 03/17

Company Director Buy

Faulkes Martin Charles

X

Direct ownership

Acquired 58,034 Common Stock at $2.60

4.49%

Apr 03/17

Mar 30/17

Company Director Buy

Skaff Habib

A

Direct ownership

Acquired 15,000 Stock Option (Right to Buy)

0.00%

Apr 03/17

Mar 30/17

Company Director Buy

Innes Guy Archibald

A

Direct ownership

Acquired 20,000 Stock Option (Right to Buy)

0.00%

Apr 03/17

Mar 30/17

Company Director Buy

Futcher Edward

A

Direct ownership

Acquired 15,000 Stock Option (Right to Buy)

0.00%

Apr 03/17

Mar 30/17

First-Class Insider Buy

Reynolds Cameron John

President and CEO

A

Direct ownership

Acquired 100,000 Stock Option (Right to Buy)

0.00%

Apr 03/17

Mar 30/17

Company Director Buy

Colman Alan

A

Direct ownership

Acquired 20,000 Stock Option (Right to Buy)

0.00%

Apr 03/17

Mar 30/17

Company Director Buy

Faulkes Martin Charles

A

Direct ownership

Acquired 100,000 Stock Option (Right to Buy)

0.00%

Apr 03/17

Mar 30/17

CxO Buy

Rootsaert Rodney Gerard

Secretary

A

Direct ownership

Acquired 60,000 Stock Option (Right to Buy)

0.00%

Apr 03/17

Mar 30/17

CxO Buy

TERRELL JASON BRADLEY MD

Chief Medical Officer

A

Direct ownership

Acquired 50,000 Stock Option (Right to Buy)

0.00%

Apr 03/17

Mar 30/17

CxO Buy

Micallef Jacob Vincent

Chief Scientific Officer

A

Direct ownership

Acquired 70,000 Stock Option (Right to Buy)

0.00%

Company: Volitionrx Ltd

VNRX

Stock Code:

Chart and trading summary tables represent transactions by company directors, chief executives(CEO, CFO, and senior company officers), corporate substantial shareholders, director's/executive's interest in affiliates of listed corporates, and individual substantial shareholders. Data on this page include all "Volitionrx Ltd (VNRX)" securities traded or transferred within the specified date range defined in stock screening and analysis panel beside the chart. (Note that, not all corporate insiders will record their trading price or number of shares bought/sold in their filings. The missing data are not included in the trading summary calculation). Different insider symbols in the price chart represent transaction activities on a particular date (Not Stock Trading Price). Additionally, transaction price in chart and trading summary table are adjusted for foreign currency exchange rate on the best efforts. The trading summary in net stock buying or stock selling totals are done on a best efforts basis. All data presented should be treated as estimates as it is based on insider trade filings which are subject to errors if input mistakes are made by a filers. Mouse over on signals to see the transaction details in the transaction info box. The chart is optimized for IE5 or above.

Disclaimer

InsidersLab.com focuses on tracking and monitoring insider trading activities in the US stocks market. "Insider Trading" means trading activities created by company directors, senior officers, individual substantial shareholders, and institutional shareholders. InsidersLab.com does not represent, warrant, nor endorse the accuracy, reliability, completeness or timeliness of any of the information, content, views, opinions, recommendations or advertisements (collectively, the "Materials") contained on, distributed through, or linked, downloaded or accessed from any of the services contained on the website (the "Service"), nor the quality of any products, information or other materials displayed, purchased, or obtained by you as a result of an advertisement or any other information or offer in or in connection with the Service (the "Products"). InsidersLab.com collects insider trading information from different public sources such as newspapers, financial information websites, and government statistics publications. You hereby acknowledge that any reliance upon any Materials shall be at your sole risk. In particular, none of the Materials is provided on the InsidersLab.com website or emails with a view to inviting, inducing or encouraging any person to make any kind of investment decision. Securities or other investments referred to in the Materials may not be suitable for you and you should not make any kind of investment decision in relation to them without first obtaining independent investment advice from a person authorized to give it.